Hawe E - Search Results

1

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE. Talmud PJ, et al. Among authors: hawe e. Hum Mol Genet. 2002 Nov 15;11(24):3039-46. doi: 10.1093/hmg/11.24.3039. Hum Mol Genet. 2002. PMID: 12417525

2

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

Talmud PJ, Hawe E, Miller GJ, Humphries SE. Talmud PJ, et al. Among authors: hawe e. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1918-23. doi: 10.1161/01.atv.0000035521.22199.c7. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426225

3

Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels.

Wong WM, Hawe E, Li LK, Miller GJ, Nicaud V, Pennacchio LA, Humphries SE, Talmud PJ. Wong WM, et al. Among authors: hawe e. Circ Res. 2003 May 16;92(9):969-75. doi: 10.1161/01.RES.0000069688.94567.7A. Epub 2003 Apr 3. Circ Res. 2003. PMID: 12676816

4

Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.

Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ. Humphries SE, et al. Among authors: hawe e. Lancet. 2001 Jul 14;358(9276):115-9. doi: 10.1016/S0140-6736(01)05330-2. Lancet. 2001. PMID: 11463413

5

Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.

Talmud PJ, Hawe E, Robertson K, Miller GJ, Miller NE, Humphries SE. Talmud PJ, et al. Among authors: hawe e. Ann Hum Genet. 2002 Mar;66(Pt 2):111-24. doi: 10.1017/S0003480002001057. Ann Hum Genet. 2002. PMID: 12174215

6

Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study.

Hawe E, Talmud PJ, Miller GJ, Humphries SE; Second Northwick Park Heart Study. Hawe E, et al. Ann Hum Genet. 2003 Mar;67(Pt 2):97-106. doi: 10.1046/j.1469-1809.2003.00017.x. Ann Hum Genet. 2003. PMID: 12675686

7

The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4.

Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ, Humphries SE, Ordovas JM. Talmud PJ, et al. Among authors: hawe e. Ann Hum Genet. 2005 Nov;69(Pt 6):613-22. doi: 10.1111/j.1529-8817.2005.00205.x. Ann Hum Genet. 2005. PMID: 16266401

8

Analysis of gene-environment interaction in coronary artery disease: lipoprotein lipase and smoking as examples.

Talmud PJ, Hawe E, Miller GJ. Talmud PJ, et al. Among authors: hawe e. Ital Heart J. 2002 Jan;3(1):6-9. Ital Heart J. 2002. PMID: 11899592 Review.

9

Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.

Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvänne M. Flavell DM, et al. Among authors: hawe e. Circulation. 2002 Mar 26;105(12):1440-5. doi: 10.1161/01.cir.0000012145.80593.25. Circulation. 2002. PMID: 11914252

10

Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension.

Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, Luong L, Wootton PT, Miller GJ, Humphries SE, Montgomery HE. Jones A, et al. Among authors: hawe e. Hypertension. 2003 Oct;42(4):500-6. doi: 10.1161/01.HYP.0000088853.27673.D0. Epub 2003 Aug 18. Hypertension. 2003. PMID: 12925562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters